U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global market.
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
